Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease

Clin Gastroenterol Hepatol. 2019 Mar;17(4):607-609. doi: 10.1016/j.cgh.2018.08.055. Epub 2018 Aug 25.

Authors

Veeral Ajmera¹, Rohit Loomba¹

Affiliation

¹ Nonalcoholic Fatty Liver Disease Research Center, Division of Gastroenterology, University of California at San Diego, La Jolla, California.

PMID: 30153521
DOI: 10.1016/j.cgh.2018.08.055

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Liver
Non-alcoholic Fatty Liver Disease*

Grants and funding